drug
teduglutide
Marketedupdated 4mo agoby Takeda Pharmaceuticals USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying teduglutide
- phase3A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
- —A Study of Teduglutide in Japanese People With Short Bowel Syndrome
- phase3Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
- phase3A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
- —Pediatric Teduglutide Registry
Patent cliff
source: FDA Orange Bookpatents (2)
- May 1, 2026patentUS 7847061*PED
- May 1, 2026patentUS 9060992*PED
FDA exclusivities (1)
- May 16, 2026ODE-240Orphan Drug (7y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that